Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Orion Group Holdings, Inc.NYSE: ORN
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow turns positive
Q1 FY2026 financing cash flow was $52.26M, compared with -$3.23M a year earlier. Trailing-twelve-month financing cash flow was $16.09M. Over 3 fiscal years it compounded at +67.6% a year.
Context
- Financing cash flow amounted to 4.6% of revenue in FY2025, up 4.1 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly financing cash flow holds near $52.26M or moves back toward the trailing-twelve-month quarterly average of $4.02M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (39.39M) USD
- Year-over-year change
- -932.3%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (39.39M) | -932.3% |
| FY2024 | 2024-12-31 | (3.82M) | -148.9% |
| FY2023 | 2023-12-31 | 7.81M | +193.3% |
| FY2022 | 2022-12-31 | (8.37M) | -139600.0% |
| FY2021 | 2021-12-31 | 6K | — |
Financing Cash Flow vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +413.0% is the 2nd highest of 10, against a peer median of -14.3%.
- Financing cash flow amounts to 1.8% of revenue for ORN, versus a peer median of 3.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | £119.15M GBP | — | +158.4% | — | |
| LTM Apr 2026 | $83M USD | +801.0% | — | 15.8% | |
| LTM Feb 2026 | $40.32M USD | -57.0% | +14.4% | 10.3% | |
| LTM Mar 2026 | $16.09M USD | +413.0% | +67.6% | 1.8% | |
| LTM Apr 2026 | $13.13M USD | -70.5% | — | 3.2% | |
| LTM Mar 2026 | $10.52M USD | +177.1% | — | 14.4% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $9.5M USD | +45.5% | +101.8% | 3.7% |
| LTM Mar 2026 | $5.16M USD | -14.3% | -58.2% | 27.8% | |
| LTM Mar 2026 | $4.18M USD | +304.4% | — | 0.5% | |
| LTM Feb 2026 | $2.32M USD | -48.9% | -57.2% | 1.9% | |
| LTM Apr 2026 | $1.09M USD | -99.6% | — | 0.1% | |
| Peer median (excluding ORN) | — | -14.3% | +14.4% | 3.7% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Depreciation & Amortization | 30.53M | 28.87M | 30.64M | 32.73M | 21.94M |
| Deferred Income Tax | (9K) | 13K | (103K) | (27K) | 52K |
| Stock-Based Compensation | 2.4M | 2.75M | 2.04M | 4.01M | 5.45M |
| Change in Working Capital | (8.1M) | (5.24M) | 2.41M | (21.7M) | (8.56M) |
| Accounts Receivables | 8.46M | (44.03M) | (23.71M) | (850K) | (32.76M) |
| Inventory | 371K | (1.49M) | (729K) | (554K) | 787K |
| Accounts Payables | 589K | 39.37M | (4.51M) | 16.02M | 11.09M |
| Other Working Capital | (17.52M) | 910K | 31.36M | (36.31M) | 12.33M |
| Other Non-Cash Items | (10.2M) | (4.22M) | 61K | (689K) | 6.7M |
| Operating Cash Flow | 69K | 9.57M | 17.18M | 12.68M | 28.07M |
| Capital Expenditures | (16.98M) | (14.58M) | (8.91M) | (14.09M) | (38.86M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 27.6M | 4.88M | 11.08M | 2.61M | 25.16M |
| Investing Cash Flow | 10.63M | (9.7M) | 2.17M | (11.48M) | (13.7M) |
| Debt Repayment | 845K | (7.27M) | 14.84M | (30.26M) | (42.32M) |
| Common Stock Issued | 0 | 0 | 0 | 26.42M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (839K) | (1.1M) | (7.03M) | 25K | 2.93M |
| Financing Cash Flow | 6K | (8.37M) | 7.81M | (3.82M) | (39.39M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 10.7M | (8.51M) | 27.15M | (2.62M) | (25.03M) |
| Free Cash Flow | (16.91M) | (5.02M) | 8.27M | (1.42M) | (10.8M) |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.